DIN 02524309 — BENVYON 25 MG
BENVYON is a solution of Bendamustine marketed by PFIZER CANADA ULC. The full Bendamustine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02524309
- Brand name
- BENVYON
- Active ingredient
- Bendamustine
- Strength
- 25 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- PFIZER CANADA ULC
- Health Canada status
- MARKETED
- Drug class
- Alkylating agent (nitrogen mustard derivative) / antineoplastic
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Bendamustine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02496860 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 100 MG | POWDER FOR SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02509172 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 100 MG | POWDER FOR SOLUTION | JAMP PHARMA CORPORATION | DORMANT |
| 02509261 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 100 MG | POWDER FOR SOLUTION | AURO PHARMA INC | MARKETED |
| 02542005 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 100 MG | POWDER FOR SOLUTION | EUGIA PHARMA INC. | MARKETED |
| 02496852 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 25 MG | POWDER FOR SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02509164 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 25 MG | POWDER FOR SOLUTION | JAMP PHARMA CORPORATION | DORMANT |
| 02509253 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 25 MG | POWDER FOR SOLUTION | AURO PHARMA INC | MARKETED |
| 02541998 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 25 MG | POWDER FOR SOLUTION | EUGIA PHARMA INC. | MARKETED |
| 02496895 | NAT-BENDAMUSTINE | 100 MG | POWDER FOR SOLUTION | NATCO PHARMA (CANADA) INC | MARKETED |
| 02496887 | NAT-BENDAMUSTINE | 25 MG | POWDER FOR SOLUTION | NATCO PHARMA (CANADA) INC | MARKETED |
| 02392569 | TREANDA | 100 MG | POWDER FOR SOLUTION | TEVA CANADA LIMITED | MARKETED |
| 02392550 | TREANDA | 25 MG | POWDER FOR SOLUTION | TEVA CANADA LIMITED | MARKETED |